Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial
Jeong Heo, Ja‐Der Liang, Chang Won Kim, Hyun Young Woo, I‐Lun Shih, Tung‐Hung Su, Zhong‐Zhe Lin, So Young Yoo, Stanley Chang, Yasuo Urata, Pei‐Jer Chen
Topics & Concepts
Oncolytic virusMedicineHepatocellular carcinomaInternal medicineOncologyGastroenterologyProgressive diseaseCancerOncolytic adenovirusResponse Evaluation Criteria in Solid TumorsRefractory (planetary science)Adverse effectPhases of clinical researchClinical trialImmunologyChemotherapyBiologyAstrobiologyVirus-based gene therapy researchCAR-T cell therapy researchCancer Research and Treatments